ProfileGDS4718 / 213227_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 87% 88% 95% 89% 91% 90% 88% 89% 89% 90% 88% 87% 89% 87% 87% 89% 93% 84% 89% 71% 88% 89% 91% 89% 91% 88% 91% 87% 91% 84% 87% 91% 89% 88% 83% 87% 91% 88% 90% 96% 91% 89% 89% 83% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]8.7696687
GSM549102patient 115, normal, homogenized [OPG study]8.8364488
GSM549104patient 119, normal, homogenized [OPG study]10.332395
GSM549108patient 138, normal, homogenized [OPG study]9.0212789
GSM549119patient 077, normal, homogenized [OPG study]9.3422991
GSM549133patient 032, cancer, homogenized [OPG study]9.3316790
GSM549139patient 042, cancer, homogenized [OPG study]8.8660388
GSM549099patient 107, normal, homogenized [OPG study]9.0207589
GSM549109patient 139, normal, homogenized [OPG study]9.1058789
GSM549110patient 046, normal, homogenized [OPG study]9.3131390
GSM549114patient 063, normal, homogenized [OPG study]9.0464788
GSM549122patient 082, normal, homogenized [OPG study]8.7509287
GSM549134patient 033, cancer, homogenized [OPG study]9.0546989
GSM549136patient 036, cancer, homogenized [OPG study]8.8738987
GSM549140patient 044, cancer, homogenized [OPG study]8.8425987
GSM549111patient 047, normal, homogenized [OPG study]9.0939889
GSM549113patient 057, normal, homogenized [OPG study]9.8826493
GSM549132patient 031, cancer, homogenized [OPG study]8.3024884
GSM549137patient 038, cancer, homogenized [OPG study]9.0420789
GSM549142patient 047, cancer, homogenized [OPG study]6.9309271
GSM549100patient 110, normal, homogenized [OPG study]8.92188
GSM549107patient 135, normal, homogenized [OPG study]9.1523189
GSM549115patient 068, normal, homogenized [OPG study]9.5240491
GSM549116patient 072, normal, homogenized [OPG study]9.1914289
GSM549120patient 078, normal, homogenized [OPG study]9.4278591
GSM549131patient 030, cancer, homogenized [OPG study]8.9878688
GSM549118patient 074, normal, homogenized [OPG study]9.4811591
GSM549129patient 027, cancer, homogenized [OPG study]8.6405587
GSM549123patient 088, normal, homogenized [OPG study]9.36191
GSM549124patient 006, cancer, homogenized [OPG study]8.2009384
GSM549126patient 015, cancer, homogenized [OPG study]8.6909887
GSM549128patient 025, cancer, homogenized [OPG study]9.3316691
GSM549103patient 117, normal, homogenized [OPG study]9.0108389
GSM549117patient 073, normal, homogenized [OPG study]9.053288
GSM549138patient 041, cancer, homogenized [OPG study]8.2408383
GSM549141patient 045, cancer, homogenized [OPG study]8.8403987
GSM549130patient 028, cancer, homogenized [OPG study]9.320291
GSM549101patient 111, normal, homogenized [OPG study]8.8403688
GSM549105patient 128, normal, homogenized [OPG study]9.2047390
GSM549106patient 134, normal, homogenized [OPG study]10.644296
GSM549112patient 048, normal, homogenized [OPG study]9.5177291
GSM549125patient 011, cancer, homogenized [OPG study]9.0469889
GSM549127patient 024, cancer, homogenized [OPG study]8.9255989
GSM549135patient 035, cancer, homogenized [OPG study]8.3467783